Bovine Pili Shield + C

With effective immunity in one dose, Bovine Pili Shield can be administered from 8 weeks to 10 months prior to calving. Bovine Pili Shield + C can be administered anytime within 8 to 16 weeks prior to calving. This allows you the flexibility of timing your vaccination program to fit your schedule and avoid stressing close-up cows. Dairy cows can be vaccinated at dry-off.

Both Bovine Pili Shield and Bovine Pili Shield + C incorporate the exclusive Xtend® III adjuvant, which provides effective immunity with a single 1 mL dose prior to calving.

Bovine Pili Shield and Bovine Pili Shield + C protect the calf by producing antibodies that are passed through the cow’s colostrum to the calf at birth. To assure passive protection to the calf, it is vital that calves receive adequate volumes of colostrum from the dam within the first few hours after birth.

INDICATIONS: This product has been shown to be effective for the vaccination of healthy pregnant cattle to provide passive immunity in calves against disease caused by Clostridium perfringens Type C and
against colibacillosis caused by K99 piliated Escherichia coli. The duration of immunity for these antigens is unknown. For more information regarding efficacy and safety, go to productdata.aphis.usda.gov

ADJUVANT: Xtend III

DIRECTIONS: Shake well before using. Administer 1 mL intramuscularly in the neck 8 to 16 weeks prior to calving. Vaccinate dairy cows at dry-off. It is essential that newborn calves receive colostrum from the vaccinated dam. Revaccinate prior to each subsequent calving. This product may be administered to pregnant cows.

PRECAUTIONS: Store out of direct sunlight at 2° to 8°C (35° to 46°F). DO NOT FREEZE. Do not mix with other products, except as specified on this label. Use entire contents when first opened. In case of human exposure, contact a physician. Do not vaccinate within 60 days prior to slaughter. WARNING: THIS PRODUCT MAY CAUSE PERSISTENT SWELLING AT THE SITE OF INJECTION. Anaphylactic reactions may occur. Symptomatic treatment: Epinephrine. Contains thimerosal as a preservative.

Safety Data Sheet

Manufacture/Product Label